Epivario Inc

Website
3401 Grays Ferry Ave
Philadelphia, PA 19146

EpiVario Inc. is an innovative biotechnology company based in Philadelphia, PA, specializing in the development of neuroepigenetic modulators for the treatment of memory-related addiction and psychiatric disorders. Led by renowned experts in the field of neuroepigenetics, Dr. Shelley Berger and Dr. Philipp Mews, EpiVario is at the forefront of pioneering epigenetic therapeutics for modern-day treatments of neuropsychiatric disorders.

With a focus on targeting a newly discovered epigenetic process in long-term memory, EpiVario aims to revolutionize therapies for a variety of memory-related psychiatric disorders, starting with nicotine addiction. By reducing the distress associated with traumatic memories, EpiVario's treatments offer a novel and highly effective approach to treating conditions such as PTSD and substance use disorders, including opioid and alcohol addiction.

Generated from the website

Own this business?
See a problem?

You might also like

Partial Data by Infogroup (c) 2024. All rights reserved.